Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since May 26 · above the Ichimoku cloud · RSI 52 · MACD below its signal
None of the 29 investors followed here reported a position in MRAI in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MRAI trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Johnson Steve AndrewChief Financial Officer | Purchase at price 0.62 per share. | 1.1K | $682 |
| May 28, 2026 | Eitan Yaron IDirector | Stock Award(Grant) at price 0.00 per share. | 175K | — |
| May 28, 2026 | Pons Robert MDirector | Stock Award(Grant) at price 0.00 per share. | 100K | — |
| May 28, 2026 | Shiv SagivDirector | Stock Award(Grant) at price 0.00 per share. | 125K | — |
| May 28, 2026 | Calabrese Jennifer RosarioDirector | Stock Award(Grant) at price 0.00 per share. | 100K | — |
| May 28, 2026 | Diclaudio ColleenDirector | Stock Award(Grant) at price 0.00 per share. | 125K | — |
| May 28, 2026 | Lamendola DamienChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 300K | — |
| May 28, 2026 | Johnson Steve AndrewChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 125K | — |
| May 19, 2026 | Eitan Yaron IDirector | Purchase at price 0.27 per share. | 10K | $2.70K |
| Feb 18, 2026 | Shiv SagivDirector | Stock Award(Grant) at price 0.00 per share. | 100K | — |
| Nov 6, 2025 | Eitan Yaron IDirector | Purchase at price 1.42 per share. | 100K | $141.50K |
| Nov 6, 2025 | Pons Robert MDirector | Purchase at price 1.42 per share. | 50K | $70.75K |
| Nov 6, 2025 | Shiv SagivDirector | Purchase at price 1.42 per share. | 50K | $70.75K |
| Nov 6, 2025 | Scrip DallasChief Operating Officer | Stock Award(Grant) at price 1.42 per share. | 100K | $141.50K |
| Oct 19, 2025 | Eitan Yaron IDirector | Stock Award(Grant) at price 0.00 per share. | 125K | — |
| Oct 19, 2025 | Shiv SagivDirector | Stock Award(Grant) at price 0.00 per share. | 75K | — |
| Oct 19, 2025 | Calabrese Jennifer RosarioDirector | Stock Award(Grant) at price 0.00 per share. | 50K | — |
| Oct 19, 2025 | Lamendola DamienChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 550K | — |
| Oct 19, 2025 | Johnson Steve AndrewChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 275K | — |
| Oct 5, 2025 | Intelligent Fanatics Capital Management LlcBeneficial Owner of more than 10% of a Class of Security | Sale at price 1.40 - 1.63 per share. | 188K | $270.64K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 24.9 | -28.8 | -48.3 | -6.9 | 177.0 | 6.3 | 180.5 | 5.8 | 42.4 | -4.8 | +407.1% | ||
| 2025 | 5.3 | -9.0 | 12.1 | -2.0 | 39.5 | -3.2 | -3.0 | 7.6 | -3.5 | 6.6 | -31.0 | -36.9 | −33.6% |
| 2024 | -30.3 | 17.2 | 70.6 | -16.8 | -68.4 | 6.1 | -23.5 | 5.8 | 0.9 | 69.4 | 70.2 | -40.6 | −45.7% |
| 2023 | 27.6 | 5.5 | 3.0 | -34.6 | 10.0 | -40.5 | 4.1 | -50.6 | -24.9 | -39.2 | 412.4 | -15.0 | −39.2% |
| 2022 | -47.0 | -13.8 | -10.0 | -11.1 | -23.7 | -20.7 | -16.3 | 16.1 | 10.8 | -15.4 | 10.6 | -26.0 | −83.6% |
| 2021 | -31.4 | 14.1 | −21.8% |
No analyst coverage for this instrument.
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.